GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire 03-05 IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
GlobeNewswire 03-05 Sandoz announces nominations to the Board of Directors and leadership change
GlobeNewswire 02-26 IO Biotech to Present at 44th Annual Cowen Health Care Conference
GlobeNewswire 02-07 Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...
TeleTrader 02-01 US opens higher, recovers from Wednesday's losses
TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B
TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 01-09 C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted ...
GlobeNewswire 2023-12-21 IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
GlobeNewswire 2023-12-07 Compass Pathways appoints Teri Loxam as Chief Financial Officer
GlobeNewswire 2023-12-04 Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire 2023-11-15 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire 2023-11-13 IO Biotech Announces 2023 Third Quarter Results
GlobeNewswire 2023-11-13 Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-11-10 IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
GlobeNewswire 2023-11-08 IO Biotech Announces Participation in Upcoming Investor Conferences
GlobeNewswire 2023-11-08 AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for ...
GlobeNewswire 2023-11-07 Arbutus Announces CEO, William Collier, to Retire December 31, 2023
GlobeNewswire 2023-11-06 Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...
GlobeNewswire 2023-11-01 IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Me...
GlobeNewswire 2023-10-31 Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combinat...
TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B
Newsfile Corp 2023-10-26 Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs